Antimicrobial Drugs / Antibacterials

Trimethoprim–sulfamethoxazole

Folate pathway inhibitors · Sequential folate blockade

Recall prompt

What is the mechanism of action of Trimethoprim–sulfamethoxazole?

Reveal answer

Sulfamethoxazole competes with PABA at dihydropteroate synthase. Trimethoprim inhibits microbial dihydrofolate reductase.

Mechanism of action

Sulfamethoxazole competes with PABA at dihydropteroate synthase. Trimethoprim inhibits microbial dihydrofolate reductase.

Drug-specific action

Blocks sequential folate steps. Hyperkalemia from trimethoprim and sulfonamide hypersensitivity are high-yield distinctions.

Bacterial coverage

Look up spectrum
Group A strep
Variable
MSSA
Typical
MRSA
Variable
E. faecalis
Gap
VRE E. faecium
Gap
E. coli
Variable
H. influenzae
Variable
P. aeruginosa
Gap
B. fragilis group
Gap
Respiratory atypicals
Gap
TypicalVariableGapUnrated

Typical means a recognized spectrum target. Variable means activity depends on resistance, species within a group, or formulation. Gap means no dependable activity for that target. These are study patterns. Clinical decisions require local susceptibility, infection site and drug exposure.

Enterococcal activity is unreliable in vivo. Do not infer streptococcal activity from MRSA activity.

Sources

Sketchy Pharm · class review, PDF p. 15 Katzung & Trevor, 13th ed. · ch. 46